BIONOMICS LIMITED (BNOX)
Institutional ownership reported to the SEC as of Q3 2024, across 12 quarters.
8
Reporting holders
$1.1M
Reported value
0.0%
Held as options
-5
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $699.8K | 1,593,000 | 0.01% | 2q | +29.9%+$160.9K |
| Lynx1 Capital Management LP | $241.5K | 549,673 | 0.09% | 5q | -8.3%-$22.0K |
| Point72 Asset Management, L.P. | $138.8K | 316,000 | 0.00% | 8q | HELD |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14.9K | 34,138 | 0.00% | new | NEW |
| RHUMBLINE ADVISERS | $3.6K | 8,300 | 0.00% | 5q | +278.1%+$2.7K |
| MORGAN STANLEY | $393 | 894 | 0.00% | 4q | +12.6% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $133 | 303 | 0.00% | new | NEW |
| Aspire Private Capital, LLC | $88 | 200 | 0.00% | 5q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2024 | 8 | $1.1M | 2,502,508 | 2 | 3 | 1 | 0.0% |
| Q2 2024 | 13 | $1.7M | 2,266,868 | 3 | 4 | 2 | 0.0% |
| Q1 2024 | 10 | $1.2M | 1,184,259 | 3 | 2 | 4 | 0.0% |
| Q4 2023 | 9 | $2.1M | 1,390,985 | 3 | 2 | 2 | 0.0% |
| Q3 2023 | 9 | $6.5M | 2,395,750 | 7 | 1 | 1 | 0.0% |
| Q2 2023 | 3 | $575.1K | 261,417 | 0 | 0 | 2 | 0.0% |
| Q1 2023 | 3 | $686.8K | 264,153 | 0 | 0 | 1 | 0.0% |
| Q4 2022 | 4 | $1.6M | 349,806 | 1 | 1 | 1 | 0.0% |
| Q3 2022 | 3 | $1.5M | 222,104 | 1 | 0 | 0 | 0.0% |
| Q2 2022 | 2 | $1.5M | 221,978 | 0 | 0 | 1 | 0.0% |
| Q1 2022 | 3 | $3.4M | 399,173 | 0 | 0 | 2 | 0.0% |
| Q4 2021 | 5 | $5.5M | 439,206 | 4 | 0 | 0 | 0.0% |